Formulation and Evaluation of Nanosuspension of Anti-cancer Drug: Design and In-vitro Evaluation of Human Serum Albumin Loaded Paclitaxel Nanosuspension - Yedla Anil Chowdary - Books - LAP LAMBERT Academic Publishing - 9783659211102 - August 10, 2012
In case cover and title do not match, the title is correct

Formulation and Evaluation of Nanosuspension of Anti-cancer Drug: Design and In-vitro Evaluation of Human Serum Albumin Loaded Paclitaxel Nanosuspension

Price
HK$ 370
excl. VAT

Ordered from remote warehouse

Expected to be ready for shipping Sep 18 - 24
Get notified about new Yedla Anil Chowdary releases
Add to your iMusic wish list

Not rated yet

Paclitaxel is a anti-cancer agent, mainly used in the cases of Breast, Cervical and Lung cancers. To increasing bio availability and Extending circulation time (EPR effect) of the drug in blood thereby increasing its half-life. Paclitaxel nanosuspension was prepared by high pressure homogenization method using different concentration of Human Serum Albumin (HSA). A total of 9 formulations of nanosuspensions were prepared by varying concentration of Human Serum Albumin (HSA) and by keeping the drug concentration as constant. All the formulations were developed successfully and evaluation tests have been performed. Human Serum Albumin in different concentrations like 12.5%, 20% and 30% showed very good results

Media Books     Paperback Book   (Book with soft cover and glued back)
Released August 10, 2012
ISBN13 9783659211102
Publishers LAP LAMBERT Academic Publishing
Pages 116
Dimensions 150 × 7 × 225 mm   ·   191 g
Language German